Skip to content

Pregabalin and Hypotensive Anesthesia

Pregabaline Effects on Hypotensive Anesthesia during Spine Surgery.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201710002516280
Enrollment
106
Registered
2017-08-14
Start date
2017-08-07
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases Surgery spine surgery

Interventions

Sponsors

faculty of medicine, Mansoura universisty
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - aged 18¿55 years, - American Society of Anesthesiologists (ASA) score I-II - admitted to undergo elective lumbar discectomy or spinal fixation surgery under general anesthesia

Exclusion criteria

Exclusion criteria: - Patients on anti-hypertensive treatment, diuretics, corticosteroids, pregabalin, gabapentin, anticonvulsants, antipsychotics, alcohol addiction, drug abuse or any analgesics within 48 hours before surgery. - patients with history of allergy to any drug used in the study. - pregnant or nursing women. - patients with peripheral neuropathy, endocrinal diseases, bleeding abnormality, cardiac, hepatic or renal impairment.

Design outcomes

Primary

MeasureTime frame
Intraoperative consumption of nitroglycerin to maintain the target MAP 55- 65 mmHg.

Secondary

MeasureTime frame
estimated blood loss ;The number of transfused blood unites;heart rate (HR) and invasive MAP;end-tidal isoflurane concentration;Surgeon satisfaction about the field (scale 0-5);Sedation (by Ramsay sedation scale);The time to the first request of analgesia.;Postoperative pain (by VAS 0-10 scale);The total morphine consumption;Frequency of adverse effects as dizziness, headache, nausea and vomiting, or pruritus.;Peak and plateau airway pressures

Countries

Egypt

Contacts

Public ContactAlaa Mazy

associate profesor of anesthesia and surgical intensive care

alaa_mazy@yahoo.com002050 01140065052

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026